Survival in Medical Technology
Navigation Links
Survival in Medical Technology
... significantly prolonged progression-free survival (PFS) compared with FOLFOX alone in the ... "Not only is the improvement in progression-free survival limited to patients with wild-type KRAS tumors, ... primary endpoint of the study is progression-free survival by KRAS status and secondary endpoints include ...
... tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose ... Data showed that the projected five-year survival rate is 54% at a median follow up of 4.5 years ... remarkable long-term, progression-free survival after completing the vaccine therapy, even though ...
... objectives of the study are to evaluate: overall survival (OS), progression-free survival (PFS), the objective response rate (ORR), and to ... benefit rate (CBR), median progression-free survival (PFS) and OS, compared with G/C alone. BSI-201 + ...
... growth, but that perifosine also improved the survival of mice bearing neuroblastoma tumors. Moreover, ... children, less than 10% will achieve long-term survival after standard multimodal therapy. ... Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of ...
... Blood transfusions may be necessary to ensure survival when a patient is bleeding heavily or has severe ... surgery study, researchers evaluated long-term survival of 9,079 patients at eight hospitals and showed ... Blood Cell Transfusions and Decreased Long-Term survival After Cardiac Surgery. Anesthesia & Analgesia ...
... received BSI-201 had a median progression-free survival of 6.9 months and overall survival of 9.2 months compared with 3.3 and 5.7 months, ... alone. The hazard ratios for progression free survival ...
... study patients over approximately 36 months, the survival rate for 97 percent of those patients was two years and the three-year progression free survival rate was 86 percent. Research was supervised ... experience recurring carcinoma tumors. The survival rate for advanced HNSCC is less than 40 percent. ...
... Overall Response Rate as well as Extends Overall survival vs. Capecitabine + Placebo in Patients with 2nd ... not a primary endpoint in the study, overall survival was analyzed with results as follows: ... + Placebo 16.3 {95% CI (5.3, 17.1)} * survival calculated from date of randomization until date ...
... - Interim median progression-free survival of at least six months By contrast, no ... without the BRAF mutation, and progression-free survival was less than two months, consistent with ... improvements in the health, quality of life and survival of patients. In 2008, Roche had over 80,000 ...
... significant increase in progression-free survival at three years for women with locally advanced ... (p=0.029) increase in progression-free survival at three years for patients treated with the ... "Lilly continues to look for ways to improve the survival of people living with cancer and fill unmet needs ...
... Overall Response Rate as well as Extended Overall survival vs. Capecitabine + Placebo in Patients with 2nd ... not a primary endpoint in the study, overall survival was analyzed with results as follows: ... treatment. **As of May 2009, median overall survival in the perifosine + capecitabine patient ...
... significant improvement in progression-free survival (PFS), the length of time a patient lives without ... P=0.004, Lung Cancer Symptom Scale). Overall survival in both studies showed a positive trend, although ... diagnosed at the advanced stage, when five year survival falls to approximately 15%(6). ...
... as response rate (RECIST), and progression-free survival (PFS) in RCC patients who failed a prior VEGF ... weeks [95% CI (11.9, 19)]. The median overall survival has not been reached with 33 of 46 patients (72%) ... cancer is confined to the kidney, the five-year survival rate is 60 to 70 percent; but ...
... The secondary endpoints of progression-free survival (PFS) and categorical change in FVC were also met ... FVC and secondary endpoints of progression-free survival and categorical change in percent predicted FVC. ... and symptoms increase in severity. The median survival time from diagnosis is two to five years, with a ...
... is designed to detect an improvement in overall survival in patients receiving talactoferrin, and results ... this Phase II trial had a median progression-free survival of 6.4 months, median overall survival of 21.1 months, and a ...
... Clinical Science program that show real-word survival rates for implantable cardiac device patients ... LATITUDE(R) Patient Management system. Five-year survival rate data for patients using implantable ... system, include: Five-year survival rates for ICD patients of up to 92 percent ...
... - Extended Median survival by 4.1 Months and Increased 3-Year survival by 38 Percent Compared to Placebo - - First ... Cellular Immunotherapy for Cancer to Prolong survival - - Company to Host Webcast at 5:30 pm ET - ...
... "We believe that picoplatin will provide a survival benefit for SCLC patients who have failed platinum-based therapy consistent with survival data we have previously generated in two ... is event-driven and we expect that the overall survival data from the SPEAR trial will show a ...
... Phase 1 data. Additionally, extended Phase 1 survival data was reported. To view the Multimedia ... Florida." Commenting on extended long-term survival data now available for subjects who participated ... Thompson noted, "There was an improvement in survival for those subjects achieving an objective ...
... be well tolerated, with a median progression-free survival in responding patients of 10.9 months. Median overall survival still has not been reached now at 17 months. Nine ... Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of ...
... renal cell carcinoma that can increase overall survival in comparison with Pfizer's Sutent would earn a ... (Metastatic): Axitinib's Improvements in Overall survival will Differentiate it from Current and Emerging Therapies finds that a therapy's effect on overall survival is the attribute that most influences surveyed ...
... without DCVax(R)-Brain have a median survival of only 14.6 months, and less than 5% of these ... patients have lived longer than the median survival of 14.6 months with existing standard of care ... longer than the median progression free survival of 6.9 months with existing standard of care ...
... significantly prolonged both disease-free survival and recurrence-free survival. Study details ... survival. Recurrence-free survival, overall survival and bone-mineral density were secondary endpoints. Disease-free survival was defined as the length of time after ...
... N.J., Jan. 13 /PRNewswire-FirstCall/ -- Overall survival results from a 14-month follow-up of the ... XELOX) significantly improved progression-free survival by investigator assessment compared to ... Head, Medical Affairs, Roche. "With these overall survival data in advanced colorectal cancer, we have ...
... objective response rate (ORR), progression-free survival (PFS) and overall survival (OS), and to describe the safety profile of ... progression-free at four months. Median overall survival was not attained at the time of evaluation. ...
... endpoints included response rate, overall survival and safety. Response rates (the ... versus 26% respectively; p= 0.0085). Overall survival data were not yet mature; a final protocol-specified survival analysis is planned after the occurrence of 485 ...
... Group (BIG) 1-98 study. The suggested survival benefit from the ITT analysis is important ... these are the first data to suggest a survival benefit for an aromatase inhibitor versus ... For the first time, we are seeing suggested survival benefit with aromatase inhibitor therapy for five ...
... response (PR). The median progression-free survival (PFS) for the 21 patients (70%) who achieved at ... patients are still alive and the median overall survival has not been reached at 16.8 months. Ten ... Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of ...
... Data Showed Campath May Lead to Overall survival in Patients with Poor Prognostic Factors ... a poor prognosis including significantly inferior survival compared to other CLL patients. Past studies have ... with Campath resulted in progression free survival (PFS) and ...
... Phase III VISTA(1) trial showing continued survival improvement for patients with previously ... prednisone continued to demonstrate a long-term survival advantage for patients with previously untreated ... the impact of subsequent therapy on the overall survival (OS) results. The updated results, which were ...
... tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose ... Data showed that the projected five-year survival rate is 54% at a median follow up of 4.5 years ... remarkable long-term, progression-free survival after completing the vaccine therapy, even though ...
... objectives of the study are to evaluate: overall survival (OS), progression-free survival (PFS), the objective response rate (ORR), and to ... benefit rate (CBR), median progression-free survival (PFS) and OS, compared with G/C alone. BSI-201 + ...
... growth, but that perifosine also improved the survival of mice bearing neuroblastoma tumors. Moreover, ... children, less than 10% will achieve long-term survival after standard multimodal therapy. ... Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of ...
Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
... genetic factors as the potential source of the survival gap. "When you look at the dialogue about the issue of race and cancer survival that's gone on over the years," says the paper's ... fact no statistically significant difference in survival based on race for a number of other cancers -- ...Alfacell Provides Shareholder Update
... we did not meet our primary endpoint of overall survival in our Phase IIIb clinical trial in patients ... who failed a prior chemo therapy. Overall survival was 10.5 months for this group. As we reported in ... requested by the FDA exhibiting a significant survival advantage for those individuals previously ...... Blood transfusions may be necessary to ensure survival when a patient is bleeding heavily or has severe ... surgery study, researchers evaluated long-term survival of 9,079 patients at eight hospitals and showed ... Blood Cell Transfusions and Decreased Long-Term survival After Cardiac Surgery. Anesthesia & Analgesia ...
... received BSI-201 had a median progression-free survival of 6.9 months and overall survival of 9.2 months compared with 3.3 and 5.7 months, ... alone. The hazard ratios for progression free survival ...
CuraGen Updates CR011-vcMMAE Data at ASCO
... 5.3 months. The median overall progression-free survival (PFS) was 4.4 months. Tumor shrinkage was ... is poor, and studies have shown that the median survival is less than nine months. About Breast ... Despite recent advances in therapy, the median survival of patients with metastatic breast cancer is 2 to ...... study patients over approximately 36 months, the survival rate for 97 percent of those patients was two years and the three-year progression free survival rate was 86 percent. Research was supervised ... experience recurring carcinoma tumors. The survival rate for advanced HNSCC is less than 40 percent. ...
... Overall Response Rate as well as Extends Overall survival vs. Capecitabine + Placebo in Patients with 2nd ... not a primary endpoint in the study, overall survival was analyzed with results as follows: ... + Placebo 16.3 {95% CI (5.3, 17.1)} * survival calculated from date of randomization until date ...
TNFerade(TM) Phase III Data Presented at ASCO
... Md., June 1 /PRNewswire-FirstCall/ -- Overall survival data in locally advanced pancreatic cancer ... the PACT trial. This interim analysis of overall survival was conducted after the 92nd death (one-third of ... to reach maturity, we are encouraged by the survival trend being observed at this point in the trial." ...... - Interim median progression-free survival of at least six months By contrast, no ... without the BRAF mutation, and progression-free survival was less than two months, consistent with ... improvements in the health, quality of life and survival of patients. In 2008, Roche had over 80,000 ...
... significant increase in progression-free survival at three years for women with locally advanced ... (p=0.029) increase in progression-free survival at three years for patients treated with the ... "Lilly continues to look for ways to improve the survival of people living with cancer and fill unmet needs ...
... Overall Response Rate as well as Extended Overall survival vs. Capecitabine + Placebo in Patients with 2nd ... not a primary endpoint in the study, overall survival was analyzed with results as follows: ... treatment. **As of May 2009, median overall survival in the perifosine + capecitabine patient ...
... significant improvement in progression-free survival (PFS), the length of time a patient lives without ... P=0.004, Lung Cancer Symptom Scale). Overall survival in both studies showed a positive trend, although ... diagnosed at the advanced stage, when five year survival falls to approximately 15%(6). ...
... as response rate (RECIST), and progression-free survival (PFS) in RCC patients who failed a prior VEGF ... weeks [95% CI (11.9, 19)]. The median overall survival has not been reached with 33 of 46 patients (72%) ... cancer is confined to the kidney, the five-year survival rate is 60 to 70 percent; but ...
Senesco Announces H1N1 Influenza Survival Test Results in Mice
... ) today reported results of H1N1 mouse influenza survival studies that were conducted in Dr. William ... siRNA against Senesco's Factor 5A gene had a 52% survival rate as opposed to a 14% survival rate for mice that received no treatment or a ...... The secondary endpoints of progression-free survival (PFS) and categorical change in FVC were also met ... FVC and secondary endpoints of progression-free survival and categorical change in percent predicted FVC. ... and symptoms increase in severity. The median survival time from diagnosis is two to five years, with a ...
... is designed to detect an improvement in overall survival in patients receiving talactoferrin, and results ... this Phase II trial had a median progression-free survival of 6.4 months, median overall survival of 21.1 months, and a ...
... Clinical Science program that show real-word survival rates for implantable cardiac device patients ... LATITUDE(R) Patient Management system. Five-year survival rate data for patients using implantable ... system, include: Five-year survival rates for ICD patients of up to 92 percent ...
Prostate Cancer Immunotherapy Significantly Prolongs Survival in Men With Advanced Prostate Cancer
... an experimental immunotherapy improved survival in men with metastatic disease, according to new ... Compared to placebo, sipuleucel-T extended median survival by 4.1 months and improved three-year survival by 38 percent. Sipuleucel-T successfully exceeded ...... - Extended Median survival by 4.1 Months and Increased 3-Year survival by 38 Percent Compared to Placebo - - First ... Cellular Immunotherapy for Cancer to Prolong survival - - Company to Host Webcast at 5:30 pm ET - ...
HeartWare International Clinical Trial Shows 90% Survival at 180 Days
... across 5 participating centers. The data show a survival rate of 90% at 6 months and a survival rate of approximately 86% at 12 months post ... the ISHLT meeting 12 months ago we reported a 90% survival among our initial patient cohort. It is pleasing ...Elusys' Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
... - Anthim Dramatically Improves survival in Animals with Clinical Symptoms of Anthrax ... A single dose of Anthim provided a significant survival benefit (up to 94 percent survival in treated rabbits vs. 0 percent in controls) ...... "We believe that picoplatin will provide a survival benefit for SCLC patients who have failed platinum-based therapy consistent with survival data we have previously generated in two ... is event-driven and we expect that the overall survival data from the SPEAR trial will show a ...
Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
... Ability of Adecatumumab to Prolong Disease Free survival in High Risk Patients with Liver Metastases ... The primary endpoint will be the disease-free survival rate at one year. "The relapse of ... of their disease. The only chance of long-term survival comes with curative resection of hepatic ...... Phase 1 data. Additionally, extended Phase 1 survival data was reported. To view the Multimedia ... Florida." Commenting on extended long-term survival data now available for subjects who participated ... Thompson noted, "There was an improvement in survival for those subjects achieving an objective ...
... be well tolerated, with a median progression-free survival in responding patients of 10.9 months. Median overall survival still has not been reached now at 17 months. Nine ... Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of ...
... renal cell carcinoma that can increase overall survival in comparison with Pfizer's Sutent would earn a ... (Metastatic): Axitinib's Improvements in Overall survival will Differentiate it from Current and Emerging Therapies finds that a therapy's effect on overall survival is the attribute that most influences surveyed ...
... without DCVax(R)-Brain have a median survival of only 14.6 months, and less than 5% of these ... patients have lived longer than the median survival of 14.6 months with existing standard of care ... longer than the median progression free survival of 6.9 months with existing standard of care ...
... significantly prolonged both disease-free survival and recurrence-free survival. Study details ... survival. Recurrence-free survival, overall survival and bone-mineral density were secondary endpoints. Disease-free survival was defined as the length of time after ...
Implantable Defibrillators Lower Risk of Death in Older Heart Patients
... with reduced heart function. -- This survival benefit applied to patients 75 years and older in ... cardioverter defibrillators (ICDs) can improve survival in patients with heart damage --- even those in ... age 75 or older, they found that the level of survival benefit remained intact. But the benefit ...... N.J., Jan. 13 /PRNewswire-FirstCall/ -- Overall survival results from a 14-month follow-up of the ... XELOX) significantly improved progression-free survival by investigator assessment compared to ... Head, Medical Affairs, Roche. "With these overall survival data in advanced colorectal cancer, we have ...
... objective response rate (ORR), progression-free survival (PFS) and overall survival (OS), and to describe the safety profile of ... progression-free at four months. Median overall survival was not attained at the time of evaluation. ...
... endpoints included response rate, overall survival and safety. Response rates (the ... versus 26% respectively; p= 0.0085). Overall survival data were not yet mature; a final protocol-specified survival analysis is planned after the occurrence of 485 ...
... Group (BIG) 1-98 study. The suggested survival benefit from the ITT analysis is important ... these are the first data to suggest a survival benefit for an aromatase inhibitor versus ... For the first time, we are seeing suggested survival benefit with aromatase inhibitor therapy for five ...
... response (PR). The median progression-free survival (PFS) for the 21 patients (70%) who achieved at ... patients are still alive and the median overall survival has not been reached at 16.8 months. Ten ... Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of ...
... Data Showed Campath May Lead to Overall survival in Patients with Poor Prognostic Factors ... a poor prognosis including significantly inferior survival compared to other CLL patients. Past studies have ... with Campath resulted in progression free survival (PFS) and ...
... Phase III VISTA(1) trial showing continued survival improvement for patients with previously ... prednisone continued to demonstrate a long-term survival advantage for patients with previously untreated ... the impact of subsequent therapy on the overall survival (OS) results. The updated results, which were ...
Other ContentsinsufficiencyinsufficiencyinsufficiencyinsufficiencyinsufficiencyviolenceviolenceviolenceviolenceverrucaconjunctivitisconjunctivitisarthritisarthritisarthritisarthritisarthritisarthritisarthritiscroupgastroenteritisgastroenteritisgastroenteritisOther TagsStrStrStrStrStrStrStrStrStrPorousOther Tagsfavored 2appeals 2point 2point 3point 4point 5point 6point 7point 8point 9point 10mammalian 2mammalian 3mammalian 4mammalian 5mammalian 6mammalian 7mammalian 8mammalian 9mammalian 10majority 2majority 3majority 4majority 5majority 6majority 7majority 8majority 9majority 10increasingly 2increasingly 3increasingly 4increasingly 5increasingly 6increasingly 7increasingly 8increasingly 9learn 2learn 3learn 4learn 5learn 6learn 7learn 8learn 9learn 10
(Date:11/24/2009)... Cambridge, Md. (November 24, 2009) New research ...ic river ecosystems reveals predictable temporal p...e communities as markers for monitoring climate ch...is week in the Proceedings of the National Academ... communities in the six rivers shifted synchronous...
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day ma...ing to a new paper produced by a research team led...nto Scarborough,s vice-principal for research and ...iology at the St. George campus. , Capitalizin...he poplar tree, the research team examined how pop...
(Date:11/23/2009)..., AMES, Iowa - The only swine vaccine available f...ne herd infected with the virus. The vaccination m...ne herd diagnosed with the pandemic flu., Iowa S... science, developed the vaccine this summer and ha...s in Iowa, Kansas and Illinois for several weeks.,...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Time of day matters to thirsty trees, U of T researcher discovers 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Doctors Stand Together Against Government Takeover of Healthcare on Sept 10th in DC 56566 1Simbionix USA Corporation Announces the Appointment of Mr Paul Jensen as General Manager for its Growing eLearning and Content Business 13943 1Simbionix USA Corporation Announces the Appointment of Mr Paul Jensen as General Manager for its Growing eLearning and Content Business 13943 2Champions Biotechnology to Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 13941 1Champions Biotechnology to Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 13941 2Champions Biotechnology to Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 13941 3(Date:11/24/2009)... Web content and Internet marketin...ee leads through your website. , ... another tough year for the U.S. economy. Small bu... the strain to keep their businesses afloat and re...ing block are things like training or marketing pr...
(Date:11/24/2009)...ESTON,Va.,Nov.24/PRNewswire/--LincolnCountyHeathca...withtwosmallhospitalsandretirementcommunities,empl...fyou,reanITpersonandyou,renotgettingsuccessfulback...identofInformationServicesatLCH.Asisthecasewithman...utBettsknewheneededabackupredesigntoprotecthismiss...
(Date:11/24/2009)...ARRYTOWN,N.Y.,Nov.24/PRNewswire-FirstCall/--Regene...tspresentationatthe21stAnnualPiperJaffrayHealthcar...nisscheduledfor4:00p.m.EasternTime.Thesessionmaybe...com ,ontheInvestorRelationspage.Anarchivedversiono...throughDecember31,2009.AdditionalinformationaboutR...
(Date:11/24/2009)...who had at least one child were less likely to bec...Nov. 24 (HealthDay News) -- Having children may sl...arch suggests. , Belgian researchers followed ...oms between the ages of 22 and 38. , Women who ...ent less likely to have the disease progress to a ...
(Date:11/24/2009)...EL-AVIV,Israel,November24/PRNewswire-FirstCall/--I...chemicalscompany,todayreported,resultsforthethirdq...inancialResultsfortheThirdQuarter , Revenues:...up,24%ascomparedsequentiallywith$1,083millionforth...2008were$2,178million,reflecting,theexceptionaldem...
Breaking Medicine News(10 mins):Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:Replay 4 Customer Takes Risk, Fights for Budget to Protect Information Systems 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 2Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 4Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 5Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 6Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 7[0] We Do Web Content Offers Free Lead Generation Report[0] Replay 4 Customer Takes Risk, Fights for Budget to Protect Information Systems[0] Regeneron Announces Presentation at the 21st Annual Piper Jaffray Healthcare Conference[0] Childbirth May Slow Progression of Multiple Sclerosis[0] ICL Reports Continued Sequential Improvement for Third Quarter of 2009
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |